Medline Inc. Class A Common Stock annual gross profit for fiscal TTM was $7.0 billion, a decrease of 6.8% from $7.5 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Gross Profit (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Gross Profit | $7.0B | $7.5B | $6.3B | $5.2B | $4.6B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Gross Profit (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|
| Gross Profit | $1.7B | $1.9B | $1.7B | $1.7B | $1.6B | $1.6B | $1.5B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More MDLN metrics: Revenue · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All MDLN financial statements → Interactive MDLN charts →
About TickerBase · Data methodology & sources